|
Index of reports
> Cases with Dehydration ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zofran (Ondansetron) where reactions include dehydration. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Zofran side effects in 54 year old female
Reported by a physician from United States on 2012-08-13
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline HCL
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-11
MS Contin
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Unknown Medication
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Vitamin B-12; Ascorbic Acid; Pamidronate Disodium; Vitamine E; Multiple Vitamin; Folic Acid; Vitamin D
Possible Zofran side effects in 54 year old female
Reported by a physician from United States on 2012-07-17
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Theragran-M / 00610701 /; Vitamin D; Folic Acid; B12 / 00056201 /; Vitamin C / 00008001 /; Pamidronate Disodium; Vitamin E / 00110501 /
Possible Zofran side effects in 54 year old female
Reported by a physician from United States on 2012-07-13
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Vitamin D; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin C / 00008001 /; Vitamin E / 00110501 /; Pamidronate Disodium; Folic Acid
Possible Zofran side effects in 54 year old female
Reported by a physician from United States on 2012-07-06
Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)
Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Blood Creatine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aleve
Dosage: 220 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-13
Doxycycline Hyclate
Dosage: 100 mg, bid
Administration route: Oral
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-20
Motrin
Dosage: 800 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2011-12-19
End date: 2012-06-12
MS Contin
Dosage: 15 mg, bid
Administration route: Oral
Indication: Pain
Start date: 2012-06-12
End date: 2012-06-12
Study Drug
Dosage: 45 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2012-05-29
End date: 2012-06-18
Zofran
Dosage: 4 mg, q6h
Indication: Nausea
Start date: 2012-06-17
End date: 2012-06-19
Other drugs received by patient: Pamidronate Disodium; Folic Acid; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin E / 00110501 /; Vitamin C / 00008001 /; Vitamin D
Possible Zofran side effects in 43 year old female
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: 43 year old female
Reactions: Weight Decreased, Migraine, Vomiting, Restless Legs Syndrome, Iron Deficiency, Constipation, Abdominal Discomfort, Malaise, Dehydration
Drug(s) suspected as cause:
Temodar
Dosage: 800mg three times per day
Administration route: Oral
Indication: Malignant Melanoma
Start date: 2010-10-01
End date: 2010-12-01
Zofran
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Blood Pressure Medication; Prozac; Ativan
Possible Zofran side effects in female
Reported by a consumer/non-health professional from Australia on 2012-03-22
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Nausea, Maternal Exposure During Pregnancy, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zofran
Possible Zofran side effects in female
Reported by a consumer/non-health professional from Australia on 2012-03-05
Patient: female
Reactions: Nausea, Dehydration, Maternal Exposure During Pregnancy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zofran
Possible Zofran side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-21
Patient: 53 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Pain, Oesophageal Obstruction, Skin Ulcer, Hypocalcaemia, Abdominal Distension, Decreased Appetite, Malabsorption, Vomiting, Stomatitis, Hyperglycaemia, Hypotension, Device Intolerance, Abdominal Infection, Sepsis, Dehydration, Hypoalbuminaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Head and Neck Cancer
Start date: 2008-08-18
End date: 2008-08-18
Percocet
Zofran
|
